The Diagnostics Pipeline: FDA Launches Pilot for Cancer Companion Diagnostic LDTs
New program aims to provide greater transparency on the recommended performance characteristics of such tests.
Subscribe to Clinical Diagnostics Insider to view
Start a Free Trial for immediate access to this article